Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    20399876 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Relapsed Malignant Blood Cancer After Allogeneic Hematopoietic Stem Cell Transplantation
Conditions: Chronic Myelogenous Leukemia;   Acute Myelogenous Leukemia;   Acute Lymphoblastic Leukemia;   Hodgkins Lymphoma;   Non-Hodgkins Lymphoma
Intervention:

Indicates status has not been verified in more than two years